Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis

Table 5 Clinical and laboratory features during index admission and discharge in two randomization arms, n (%)

	Intervention (n = 120)	Standard of care (n = 120)	P value
Index admission labs (mean ± SD)
Sodium	132.59 ± 5.58	132.28 ± 6.28	0.68
Serum creatinine (mg/dL)	1.42 ± 1.11	1.64 ± 1.47	0.19
Total bilirubin (mg/dL)	5.90 ± 9.10	6.19 ± 7.80	0.79
Albumin (g/dL)	2.83 ± 0.59	2.85 ± 0.55	0.72
INR	1.68 ± 0.52	1.70 ± 0.59	0.80
Hemoglobin (g/dL)	10.22 ± 2.34	10.02 ± 2.04	0.48
Ascites
Absent	35, 29.17	35, 29.17	0.44
Slight	26, 21.67	34, 28.33
Moderate	59, 49.17	51, 42.50
Encephalopathy
None	91, 75.83	96, 80.00	0.78
Grade 1-2	22, 18.33	18, 15.00
Grade 3-4	7, 5.83	6, 5.00
Dialysis at least twice in last week
No	117, 97.50	115, 95.83	0.72
Yes	3, 2.50	5, 4.17
Index admission discharge labs (mean ± SD)
Sodium (mmol/L)	134.72 ± 4.14	134.95 ± 3.57	0.64
Serum creatinine (mg/dL)	1.31 ± 1.06	1.37 ± 1.18	0.69
Total bilirubin (mg/dL, n = 237)	5.50 ± 8.80	5.39 ± 6.96	0.92
Albumin (g/dL, n = 237)	2.98 ± 0.64	2.94 ± 0.61	0.65
INR (n = 238)	1.71 ± 0.49	1.69 ± 0.45	0.65
Hemoglobin (g/dL)	9.30 ± 1.69	9.21 ± 1.68	0.68
Ascites
Absent	42, 35.00	39, 32.50	0.35
Slight	56, 46.67	66, 55.00
Moderate	22, 18.33	15, 12.50
Encephalopathy
None	117, 97.50	112. 93.33	0.10
Grade 1-2	2, 1.67	8, 6.67
Grade 3-4	1, 0.83	0, 0.00
Dialysis at least twice in last week
No	114, 95.00	110, 91.67	0.44
Yes	6, 5.00	10, 8.33